PRODUCT TYPES – Page 11

Cryopreservation failure during FDA inspection readiness: patient safety impact and disposition

The first step in addressing a cryopreservation failure is recognizing the symptoms or signals that indicate an issue may have occurred. Symptoms can manifest in various ways, such as:Click to…

Finished product preservative effectiveness test (PET) failure after process parameter adjustment: how to build a deviation package that passes an inspection deep-dive

The initial detection of a failure in the PET usually stems from observed symptoms during production or testing stages. Common signals may include:Click to read the full article.

Cryopreservation failure during stability testing: patient safety impact and disposition

Detecting cryopreservation failures early is critical. Notably, symptoms may manifest as:Click to read the full article.

Finished product serialization data mismatch during complaint trending review: risk assessment for patient impact and field alert / recall triggers

Detection of a serialization data mismatch typically surfaces through various internal signals, such as:Click to read the full article.

Vector potency drift during stability testing: patient safety impact and disposition

Identifying the symptoms of vector potency drift is the first critical step in addressing the issue. Terms such as Out of Specification (OOS) results during stability testing typically raise alarm…

Finished product disintegration failure after process parameter adjustment: how to build a deviation package that passes an inspection deep-dive

Identifying symptoms of disintegration failure is vital in initiating an effective investigation. Common signals include:Click to read the full article.

Cell viability failure during stability testing: patient safety impact and disposition

Identifying symptoms and signals of cell viability failure is crucial for initiating an effective investigation. Early detection often comes from specific observations and data collection methods employed during the stability…

Finished product blend uniformity failure during routine batch release: how to defend specification setting and outlier handling during inspection

Identifying blend uniformity failures during routine batch release typically starts with recognizing key symptoms that warrant further investigation. The primary signals include:Click to read the full article.

Vector potency drift during tech transfer: inspection-ready investigation package

Identifying the symptoms and signals associated with vector potency drift is the first step in a deviation investigation. Common signs include:Click to read the full article.

Finished product out-of-spec pH after process parameter adjustment: stability strategy adjustments and packaging risk mitigation steps

Identifying early signals is essential for timely intervention in pharmaceutical manufacturing. Symptoms of an out-of-specification pH can manifest in various ways:Click to read the full article.

Cryopreservation failure during FDA inspection readiness: inspection-ready investigation package

Cryopreservation Failure Investigation During FDA Inspection Readiness In an evolving pharmaceutical landscape, cryopreservation is crucial for preserving biologics, particularly in Advanced Therapy Medicinal Products (ATMPs). However, failures during cryopreservation can…

Finished product assay OOS during CPV annual product review: risk assessment for patient impact and field alert / recall triggers

Detection of an OOS result often begins with regular laboratory observations or during routine quality control checks. Symptoms may include:Click to read the full article.